Doctor profile · Federal record
Dr. JESSICA TACKETT, D.O.
Family Medicine Physician (CMS: FAMILY PRACTICE) · Student in an Organized Health Care Education/Training Program · GREENBRIER, AR
- NPI 1346509478
- Accepts Medicare
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
49 S BROADVIEW ST STE 1
GREENBRIER, AR 720588011
(501) 679-4030
Credentials & registration
- NPI registered
- May 2012 — 14 yrs on file
- Profile last updated
- September 29, 2015
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Arkansas #E9071
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346509478. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,975
Distinct HCPCS
10
Medicare allowed
$67,086
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 499 | 234 | $81 | |
36415 |
Insertion of needle into vein for collection of blood sample | 363 | 193 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 228 | 49 | $0 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 228 | 49 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 158 | 104 | $62 | |
81003 |
Automated urinalysis test | 108 | 77 | $2 | |
96372 |
Injection of drug or substance under skin or into muscle | 66 | 55 | $12 | |
87811 |
Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 58 | 48 | $38 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 52 | 22 | $16 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | 45 | $47 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 104. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$195
Transactions
10
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 2 | $47.33 | |
| Abbott Laboratories | 2 | $41.39 | |
| Exact Sciences Corporation | 2 | $32.91 | |
| Novo Nordisk Inc | 1 | $20.03 | |
| Amgen Inc. | 1 | $18.65 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18.10 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,105
Patients
679
Total drug cost
$28,629
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 283 | 76 | $3,903 |
| Lisinopril | Generic | 243 | 59 | $2,570 |
| Levothyroxine Sodium | Generic | 213 | 52 | $2,966 |
| Omeprazole | Generic | 189 | 56 | $3,169 |
| Pantoprazole Sodium | Generic | 159 | 36 | $2,835 |
| Amlodipine Besylate | Generic | 144 | 39 | $1,430 |
| Hydrochlorothiazide | Generic | 117 | 31 | $456 |
| Prednisone | Generic | 111 | 79 | $514 |
| Citalopram Hbr (Citalopram Hydrobromide) | Brand | 104 | 16 | $800 |
| Gabapentin | Generic | 100 | 28 | $2,158 |